At the conclusion of this activity, participants should better be able to:
• Optimize imaging methods to reduce the number of false-positive mammography interpretations.
• Describe recent advances and techniques in breast imaging.
• Integrate information presented in this course into efforts to improve the imaging skills of the participants.
This course is intended for Practicing Radiologists and Radiologic Nurses, Physician Assistants, Technologists, Scientists, Residents, Fellows and others who are interested in current techniques and applications for breast imaging.
Debra Ikeda, M.D.
• Professor of Radiology, Breast Imaging
• Stanford University School of Medicine
Dr. Ikeda is a tenured Professor of Radiology at Stanford and was Breast Imaging Section Chief from 1992-2016. She has published over 110 scientiﬁc articles, led (2004) or was vice-chair (2013) of the ACR BI-RADS-MRI Committee, and authored “Breast Imaging: The Requisites 3rd Edition” (2016). She is a recognized breast imaging/biopsy speaker/teacher, with over 300 presentations in the USA and around the world. Prior research focused on FFDM/DBT, needle biopsy, MRI/MRI biopsy, compliance/outcomes, density legislation. The new research involves mammographic positioning, DWI, breast cancer/stroma genetics, MRI outcomes, DBT interval cancers.
Alfred B. Watson Jr. MD MPH FACR FACPM
• Distinguished Emeritus Professor of Radiology
• Baylor College of Medicine
• Fellow of the American College of Radiology
Dr. Watson is a Distinguished Emeritus Professor of Radiology at Baylor College of Medicine and a Fellow in the Society of Breast Imaging. Dr. Watson has held the positions of Colonel USAF 1969-1984; Aeronautical Rating Chief Flight Surgeon; Chief Aerospace Medicine, Headquarters USAF Europe Office of Surgeon General, 1973-1975; Military Consultant to the USAF Surgeon General for Radiology, 1979-1984. As a member of Breast Imaging Training Advisory Committee, he helped to develop and publish the breast imaging residency and fellowship training curriculum. Dr Watson has delivered over 148 invited lectures nationally and 9 international visiting professor assignments at academic and military programs. He has delivered over 1,000 hours of CME breast lectures for residents, breast fellows, radiologists and Clinicians. Dr Watson was selected by the ABR as an Oral Board examiner in Breast Imaging 16 of the last 19 years. For his commitment and excellence, he was awarded Distinguished Service Award by the ABR in 2008, 2010 and 2014. The crowning landmark came in 2015 when ABR honored him with a Lifetime Achievement Award. In his 37-year career with the US Air Force and Baylor College of Medicine, Dr. Watson trained generations of physicians with unwavering energy and enthusiasm.
Breast Imaging BUNDLE (Programs 1-3) - Debra Ikeda M.D., Alfred Watson, M.D.
Debra Ikeda, M.D. - Program 1
- Update on MRI Screening and Diagnosis
- Update on Digital Breast Tomosynthesis Screening and Diagnosis
- Wireless Localization Techniques on Mammo, US and Stereo
- Multimodality (Mammo/US/MRI) Breast Imaging Cases
- Ultrasound and Stereotactic Core Biopsy
- Augmented/Reconstructed Breast with Lipofilling and the New Faces of Fat Necrosis on Mammo, US and MRI
- Mammography Legislation, Breast Density Legislation and Risk
Alfred Watson, M.D. - Program 2
- Imaging Breast Calcifications and Review of Benign Calcifications
- Imaging Evaluation and Discussion of Breast Asymmetry
- Morphology Criteria for Malignant Breast Calcifications
- The Male Breast - Imaging, Diagnosis, and Treatment of Male Breast Disease
- Work-Up of Palpable and Non-Palpable Mass(es)Work-Up of Palpable and Non-Palpable Mass(es)
Breast Imaging Bundle (Programs 1-3) - Debra Ikeda M.D., FACR, FSBI, Alfred Watson M.D.
17 AMA PRA Category 1 Credit(s)™
Refund Policy: Cancellations can only be made within 24 hours of purchase. Please note: If you have applied for CME credit during the 24 hour period “NO” refunds will be available. Refunds will be given less a $100.00 administrative fee.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CME Science. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 17 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty members have nothing to disclose.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CME Science planners and managers have nothing to disclose.
Method of Participation and Request for Credit
During the period May 16, 2020 through September, 30 2023, participants must read the learning objectives and faculty disclosures and study the educational activity.
Computer System Requirements
Any online accessible device.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.